LY 294002

- NSC 697286; SF 1101; LY 294002; LY-294002
货号-规格 | 货期 | 价格 | 数量 |
abs810001-10mg | 现货 | - + | |
abs810001-25mg | 现货 | - + | |
abs810001-100mg | 1-2周 | - + |

产品描述 | ||
描述 | LY294002 是首个合成的已知抑制PI3Kα/δ/β的小分子,在无细胞测定中IC50分别为 0.5μM/0.57 μM/0.97μM;在溶液中比在Wortmannin中稳定,也能够阻断自噬体的形成。 | |
纯度 | >98% | |
储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. | |
基本信息 | ||
别名 | NSC 697286; SF 1101; LY 294002; LY-294002 | |
外观 | white to off-white powder | |
可溶性/溶解性 | DMSO:36 mg/mL (117.13 mM) Ethanol:21 mg/mL (68.32 mM) | |
生物活性 | ||
靶点 | p110α,p110δ,p110β,DNA-PK | |
In vitro(体外研究) | LY294002 is not exclusively selective for the PI3Ks, and could in fact act on other lipid kinases and additional apparently unrelated proteins. LY294002 is shown to inhibit not only mTOR and DNA-PK, but also other protein kinases, such as CK2 (casein kinase 2) and Pim-1. LY294002 inactivates Akt/PKB, consequently inhibiting cell proliferation and inducing apoptosis. LY294002 demonstrates a remarkable growth-inhibitory and apoptosis-inducing effect in these colon cancer cell lines, with decreased expression of phosphorylated Akt (Ser473). LY294002 induces marked nuclear pyknosis and diminished cytoplasmic volume in the tumor cells. Thus, LY294002 markedly inhibits ovarian cancer cell proliferation in vitro. LY294002 induces specific G1 arrest in cell growth, leading to almost complete inhibition of melanoma cell proliferation and partial inhibition of MG-63 (osteosarcoma cell line) proliferation. The effect of LY294002 on cell cycle progression may provide insights into a possible link between the PI3K activation pathway and cancer cell cycle regulation. | |
In vivo(体内研究) | LY294002 also results in suppression of tumor growth and induction of apoptosis, especially in the LoVo tumors, and therefore shows remarkable effectiveness in the mouse peritonitis carcinomatosa model. LY294002 significantly inhibits growth and ascites formation of ovarian carcinoma. | |
参考文献 | ||
参考文献 | [1] Chaussade C, et al. Biochem J, 2007, 404(3), 449-58.
[2] Semba S, et al. Clin Cancer Res, 2002, 8(6), 1957-63. [3] Hu L, et al. Clin Cancer Res, 2000, 6(3), 880-6. | |
温馨提示:本产品仅作科研实验使用,不支持临床等研究 |
- 实验方法 实验条件
共 0 张,还能上传 8 张 提交
- 提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要咨询”按钮填写您的疑问。
提交不成功?请联系info@absin.cn。
- CCL19 enhances CD8+ T-cell responses and accelerates HBV clearance
Yan Yan, Wei Zhao, Wei Liu, Yan Li, Xu Wang, Jingna Xun, Chantsalmaa Davgadorj
Journal of Gastroenterology. 2021 Jul 03 .
影响因子: 7.527
- DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3β/Snail pathway
Xu Liu,Tong Li, Xinyang Huang, Wei Wu, Juanjuan Li, Lumin Wei, Yuting Qian, Hui Xu, Qi Wang, Lifu Wang
Oncology Letters. 2020 Nov 01 ; 5
影响因子: 2.967
- 3-Methyladenine Alleviates Experimental Subretinal Fibrosis by Inhibiting Macrophages and M2 Polarization Through the PI3K/Akt Pathway
Qiyu Bo, Mengxi Shen, Meichun Xiao, Jian Liang, Yuanqi Zhai, Hong Zhu, Mei Jiang, Fenghua Wang, Xueting Luo, Xiaodong Sun
J OCUL PHARMACOL TH. 2020 Oct 05 ; 8
影响因子: 3.60
- LNK deficiency decreases obesity-induced insulin resistance by regulating GLUT4 through the PI3K-Akt-AS160 pathway in adipose tissue
Xiaozhu Zhong, Chuanfeng Ke, Zhaoxi Cai, Hao Wu, Yang Ye, Xiaolin Liang, Liqun Yu, Sushi Jian , Jun Shen, Laiyou Wang, Meiqing Xie, Guanlei Wang, Xiaomiao Zhao
Aging (Albany NY). 2020 Sep 10 ; 17
影响因子: 4.831
- Phosphoinositide 3‐kinase/protein kinase B inhibition restores regulatory T cell's function in pulmonary sarcoidosis
Bin Zhang,Qianqian Dai,Xuguang Jin,Dongmei Liang,Xiaojie Li,Haiyan Lu,Yu Liu,Jingjing Ding,Qian Gao,Yanting Wen
J Cell Physiol. 2019 Nov 01 ; 11
影响因子: 4.522
- 阳和化岩汤联合LY294002对裸鼠乳腺癌及微淋巴管生成的干预作用研究
刘晓菲;李静蔚;孙庆颖;李湘奇;张洋
中药药理与临床. 2018 Dec 15 ; 6
- 温阳散结中药干预乳腺癌细胞SK-BR-3的生长抑制及诱导凋亡研究
刘晓菲;李静蔚;时光喜;李湘奇;张洋
中国医药导报. 2018 Jan 15 ; 2
促销资讯 更多